| Autor: |
Bruno Märkl, Sebastian Dintner, Tina Schaller, Eva Sipos, Elisabeth Kling, Silvia Miller, Francisco Farfán López, Przemyslaw Grochowski, Nic Reitsam, Johanna Waidhauser, Klaus Hirschbühl, Oliver Spring, Andre Fuchs, Thomas Wibmer, Peter Boor, Martin Beer, Claudia Wylezich |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
International Journal of Infectious Diseases, Vol 128, Iss , Pp 51-57 (2023) |
| Druh dokumentu: |
article |
| ISSN: |
1201-9712 |
| DOI: |
10.1016/j.ijid.2022.12.029 |
| Popis: |
Objectives: Omicron lineages BA.1/2 are considered to cause mild clinical courses. Nevertheless, fatal cases after those infections are recognized but little is known about risk factors. Methods: A total of 23 full and three partial autopsies in deceased with known Omicron BA.1/2 infections have been consecutively performed. The investigations included histology, blood analyses, and molecular virus detection. Results: COVID-19-associated diffuse alveolar damage was found in only eight cases (31%). This rate is significantly lower compared with previous studies, including non-Omicron variants, where rates between 69% and 92% were observed. Neither vaccination nor known risk factors were significantly associated with a direct cause of death by COVID-19. Only those patients who were admitted to the clinic because of COVID-19 but not for other reasons had a significant association with a direct COVID-19 –caused death (P >0.001). Conclusion: Diffuse alveolar damage still occurred in the Omicron BA.1/BA.2 era but at a considerably lower frequency than seen with previous variants of concern. None of the known risk factors discriminated the cases with COVID-19-caused death from those that died because of a different disease. Therefore, the host's genomics might play a key role in this regard. Further studies should elucidate the existence of such a genomic risk factor. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
